Tyra Biosciences Inc (TYRA) — Institutional Holders Breakdown (Q2 2026)

TYRA ranks #3382 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

TYRA is a top-conviction position for Alta Partners Management Company, L.P. — at 95.9% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in TYRA belongs to Ra Capital Management, L.p., but the position matters far more to Alta Partners Management Company, L.P., who has 95.9% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Versant Capital Management, Inc has trimmed its TYRA position for two straight quarters, cutting it by $13.5K while still holding $17.9K.

TYRA is down 2.7% today, but institutions show net buying of $303.7M this quarter — a divergence between today's price move and the underlying institutional flow.

TYRA reported a net loss of $119.9M in its latest fiscal year.

• Not yet profitable — net loss of $119.9M in the latest fiscal year
• Net income declined year over year, from -$86.5M to -$119.9M
• Operating cash flow was negative, using $95.1M in cash
• Current ratio of 14.67x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.09x equity — within a conventional range